Susquehanna International »

Nektar Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $102M 1.8M 56.90
2025-06-30 $34M 1.3M 25.84

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics